Prescriber's Corner
Eribulin Mesylate: Unique Advancement in Metastatic Breast Cancer
Kelley D. Mayden, MSN, FNP, AOCNP®
From Southwest Virginia Cancer Center, Norton, Virginia
The author has no conflicts of interest to disclose.
Correspondence to: Kelley D. Mayden, MSN, FNP, AOCNP®, 671 Highway 58 East, Norton, VA 24273. E-mail: kdunrun@charter.net
J Adv Pract Oncol 2011;2:125–128 |
DOI: 10.6004/jadpro.2011.2.2.7 |
© 2011 Harborside Press®
For access to the full length article, please
sign in.
